SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Conceptus (CPTS)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: telephonics who wrote (69)7/12/2005 1:10:07 PM
From: tuck  Read Replies (1) of 96
 
>>SAN CARLOS, Calif.--(BUSINESS WIRE)--July 12, 2005--Conceptus, Inc. (Nasdaq:CPTS - News), developer of the Essure® non-incisional permanent birth control procedure, today reported that UnitedHealthcare ("UHC") has approved the Essure procedure for reimbursement effective immediately. UHC, a UnitedHealth Group company (NYSE:UNH - News) is headquartered in Minnetonka, Minnesota, and serves more than 18 million lives across the U.S. As with all healthcare plans, coverage will vary and is dependent upon the individual's specific benefit plan.

"This is excellent news for women covered by UHC who will want to avail themselves of our non-incisional approach to permanent birth control," commented Mark Sieczkarek, president and chief executive officer of Conceptus. "We are very pleased that UHC has recognized the benefits of the Essure procedure and its continuing track record of safety, efficacy and cost effectiveness." <<

snip

Good for 18% as I type.

Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext